Cognition Therapeutics Stock Technical Analysis
| CGTX Stock | USD 0.40 0.01 2.44% |
As of the 1st of December, Cognition Therapeutics shows the Standard Deviation of 6.29, risk adjusted performance of (0.07), and Mean Deviation of 4.27. Cognition Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cognition Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cognition, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CognitionCognition |
Cognition Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 6.25 | Strong Buy | 5 | Odds |
Most Cognition analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cognition stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cognition Therapeutics, talking to its executives and customers, or listening to Cognition conference calls.
Cognition Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cognition Therapeutics Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cognition Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Cognition Therapeutics Trend Analysis
Use this graph to draw trend lines for Cognition Therapeutics. You can use it to identify possible trend reversals for Cognition Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cognition Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Cognition Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Cognition Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0017 , which may suggest that Cognition Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.11, which is the sum of squared deviations for the predicted Cognition Therapeutics price change compared to its average price change.About Cognition Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cognition Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cognition Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cognition Therapeutics price pattern first instead of the macroeconomic environment surrounding Cognition Therapeutics. By analyzing Cognition Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cognition Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cognition Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2023 | 2024 (projected) | Payables Turnover | 0.0223 | 0.0682 | 0.0395 | Days Of Inventory On Hand | 7.8K | 7.0K | 7.4K |
Cognition Therapeutics December 1, 2024 Technical Indicators
Most technical analysis of Cognition help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cognition from various momentum indicators to cycle indicators. When you analyze Cognition charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.44) | |||
| Mean Deviation | 4.27 | |||
| Coefficient Of Variation | (993.35) | |||
| Standard Deviation | 6.29 | |||
| Variance | 39.63 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.83) | |||
| Total Risk Alpha | (1.69) | |||
| Treynor Ratio | (0.45) | |||
| Maximum Drawdown | 36.32 | |||
| Value At Risk | (10.34) | |||
| Potential Upside | 8.89 | |||
| Skewness | 1.18 | |||
| Kurtosis | 4.18 |
Additional Tools for Cognition Stock Analysis
When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.